SG

Sanjay Gandha Kharwa

Active Director Designated Partner DIN 09330433
DIN 09330433 First appointment Sep 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Gandha Kharwa

Data last updated:

Sanjay Gandha Kharwa is a Designated Partner at Neumedix Pharmachem Llp (since 2021). The company operates in Pharma.

DIN 09330433
Primary Designation Designated Partner
Industry Pharma
First Appointment 23 Sep 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner23 Sep 20212021Active

Board colleagues of Sanjay Gandha Kharwa

NameDINCompanyDesignation
Gulam Mohiuddin Aslam Shaikh08150559Neumedix Pharmachem LlpDesignated Partner
Jayantilal Mohanlal Jain09330382Neumedix Pharmachem LlpDesignated Partner
Ramdhani Ramkishor Yadav08857888Neumedix Pharmachem LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Neumedix Pharmachem Llp
Premium access

Shareholding and investment profile for Sanjay Gandha Kharwa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Gandha Kharwa

Sanjay Gandha Kharwa currently holds 1 directorship: Neumedix Pharmachem Llp (Designated Partner, since 23 Sep 2021).

Sanjay Gandha Kharwa was first appointed on 23 Sep 2021 as Designated Partner at Neumedix Pharmachem Llp.

The current boards of Sanjay Gandha Kharwa's companies include Gulam Mohiuddin Aslam Shaikh (Neumedix Pharmachem Llp), Jayantilal Mohanlal Jain (Neumedix Pharmachem Llp), Ramdhani Ramkishor Yadav (Neumedix Pharmachem Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available